Lacrelax IG Granules is a pharmaceutical formulation combining Lactitol (10 gm) and Ispaghula (3.5 gm) designed to provide effective relief from constipation and promote regular bowel movements. Lactitol, a synthetic disaccharide, functions as an osmotic laxative by drawing water into the colon, thereby softening stools and facilitating easier defecation. Ispaghula, derived from the husks of Plantago ovata seeds, acts as a bulk-forming fiber that absorbs water and increases stool volume, stimulating peristalsis and enhancing intestinal motility. The synergistic action of these two components makes Lacrelax IG Granules suitable for managing chronic constipation, irritable bowel syndrome with constipation (IBS-C), and other conditions requiring gentle yet effective bowel regulation. The granules are typically administered orally, dissolved in water, and are well-tolerated with minimal side effects. Regular use under medical supervision can improve bowel habits, reduce straining, and prevent complications associated with constipation such as hemorrhoids. Lacrelax IG Granules should be used as directed by a healthcare professional, with adequate hydration to optimize therapeutic outcomes. It is contraindicated in cases of intestinal obstruction, hypersensitivity to components, or acute abdominal conditions.